vs

Side-by-side financial comparison of IRONWOOD PHARMACEUTICALS INC (IRWD) and Postal Realty Trust, Inc. (PSTL). Click either name above to swap in a different company.

IRONWOOD PHARMACEUTICALS INC is the larger business by last-quarter revenue ($47.7M vs $26.0M, roughly 1.8× Postal Realty Trust, Inc.). Postal Realty Trust, Inc. runs the higher net margin — 17.9% vs -4.8%, a 22.6% gap on every dollar of revenue. On growth, Postal Realty Trust, Inc. posted the faster year-over-year revenue change (21.7% vs -47.3%). IRONWOOD PHARMACEUTICALS INC produced more free cash flow last quarter ($74.6M vs $37.6M). Over the past eight quarters, Postal Realty Trust, Inc.'s revenue compounded faster (22.6% CAGR vs -20.2%).

Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.

Postal Realty Trust, Inc. is a specialized real estate investment trust that acquires, owns, and manages properties primarily leased to the United States Postal Service. Its portfolio includes last-mile postal facilities, sorting centers, and retail post office locations across the U.S., supporting critical mail and package delivery infrastructure.

IRWD vs PSTL — Head-to-Head

Bigger by revenue
IRWD
IRWD
1.8× larger
IRWD
$47.7M
$26.0M
PSTL
Growing faster (revenue YoY)
PSTL
PSTL
+69.0% gap
PSTL
21.7%
-47.3%
IRWD
Higher net margin
PSTL
PSTL
22.6% more per $
PSTL
17.9%
-4.8%
IRWD
More free cash flow
IRWD
IRWD
$37.0M more FCF
IRWD
$74.6M
$37.6M
PSTL
Faster 2-yr revenue CAGR
PSTL
PSTL
Annualised
PSTL
22.6%
-20.2%
IRWD

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
IRWD
IRWD
PSTL
PSTL
Revenue
$47.7M
$26.0M
Net Profit
$-2.3M
$4.6M
Gross Margin
Operating Margin
14.3%
39.2%
Net Margin
-4.8%
17.9%
Revenue YoY
-47.3%
21.7%
Net Profit YoY
-200.9%
3.1%
EPS (diluted)
$0.01
$0.16

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IRWD
IRWD
PSTL
PSTL
Q4 25
$47.7M
$26.0M
Q3 25
$122.1M
$24.3M
Q2 25
$85.2M
$23.4M
Q1 25
$41.1M
$22.1M
Q4 24
$90.5M
$21.4M
Q3 24
$91.6M
$19.7M
Q2 24
$94.4M
$18.1M
Q1 24
$74.9M
$17.3M
Net Profit
IRWD
IRWD
PSTL
PSTL
Q4 25
$-2.3M
$4.6M
Q3 25
$40.1M
$3.8M
Q2 25
$23.6M
$3.6M
Q1 25
$-37.4M
$2.1M
Q4 24
$2.3M
$4.5M
Q3 24
$3.6M
$1.1M
Q2 24
$-860.0K
$817.0K
Q1 24
$-4.2M
$206.0K
Operating Margin
IRWD
IRWD
PSTL
PSTL
Q4 25
14.3%
39.2%
Q3 25
61.8%
37.6%
Q2 25
53.2%
37.3%
Q1 25
-70.7%
28.4%
Q4 24
34.8%
43.2%
Q3 24
28.0%
24.3%
Q2 24
26.5%
22.8%
Q1 24
14.7%
17.6%
Net Margin
IRWD
IRWD
PSTL
PSTL
Q4 25
-4.8%
17.9%
Q3 25
32.8%
15.7%
Q2 25
27.7%
15.5%
Q1 25
-90.9%
9.4%
Q4 24
2.5%
21.1%
Q3 24
4.0%
5.4%
Q2 24
-0.9%
4.5%
Q1 24
-5.6%
1.2%
EPS (diluted)
IRWD
IRWD
PSTL
PSTL
Q4 25
$0.01
$0.16
Q3 25
$0.23
$0.13
Q2 25
$0.14
$0.12
Q1 25
$-0.23
$0.06
Q4 24
$0.03
$0.17
Q3 24
$0.02
$0.03
Q2 24
$-0.01
$0.02
Q1 24
$-0.03
$-0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IRWD
IRWD
PSTL
PSTL
Cash + ST InvestmentsLiquidity on hand
$215.5M
$1.5M
Total DebtLower is stronger
$361.1M
Stockholders' EquityBook value
$-261.8M
$285.2M
Total Assets
$396.9M
$759.1M
Debt / EquityLower = less leverage
1.27×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IRWD
IRWD
PSTL
PSTL
Q4 25
$215.5M
$1.5M
Q3 25
$140.4M
$1.9M
Q2 25
$92.9M
$1.1M
Q1 25
$108.5M
$639.0K
Q4 24
$88.6M
$1.8M
Q3 24
$88.2M
$970.0K
Q2 24
$105.5M
$1.7M
Q1 24
$121.5M
$1.9M
Total Debt
IRWD
IRWD
PSTL
PSTL
Q4 25
$361.1M
Q3 25
$199.5M
$347.0M
Q2 25
$199.3M
$328.8M
Q1 25
$199.2M
$306.7M
Q4 24
$199.0M
$296.7M
Q3 24
$198.8M
$277.0M
Q2 24
$198.6M
$273.7M
Q1 24
$398.3M
$247.6M
Stockholders' Equity
IRWD
IRWD
PSTL
PSTL
Q4 25
$-261.8M
$285.2M
Q3 25
$-264.2M
$273.9M
Q2 25
$-308.2M
$250.8M
Q1 25
$-334.1M
$245.5M
Q4 24
$-301.3M
$251.3M
Q3 24
$-311.3M
$245.6M
Q2 24
$-321.7M
$245.5M
Q1 24
$-330.5M
$248.1M
Total Assets
IRWD
IRWD
PSTL
PSTL
Q4 25
$396.9M
$759.1M
Q3 25
$396.1M
$735.2M
Q2 25
$342.9M
$689.8M
Q1 25
$327.2M
$654.0M
Q4 24
$350.9M
$646.8M
Q3 24
$389.5M
$615.1M
Q2 24
$395.6M
$608.2M
Q1 24
$438.8M
$584.1M
Debt / Equity
IRWD
IRWD
PSTL
PSTL
Q4 25
1.27×
Q3 25
1.27×
Q2 25
1.31×
Q1 25
1.25×
Q4 24
1.18×
Q3 24
1.13×
Q2 24
1.11×
Q1 24
1.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IRWD
IRWD
PSTL
PSTL
Operating Cash FlowLast quarter
$74.6M
$44.5M
Free Cash FlowOCF − Capex
$74.6M
$37.6M
FCF MarginFCF / Revenue
156.3%
144.5%
Capex IntensityCapex / Revenue
0.0%
26.7%
Cash ConversionOCF / Net Profit
9.59×
TTM Free Cash FlowTrailing 4 quarters
$127.0M
$65.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IRWD
IRWD
PSTL
PSTL
Q4 25
$74.6M
$44.5M
Q3 25
$47.6M
$10.9M
Q2 25
$-15.1M
$11.4M
Q1 25
$20.0M
$10.8M
Q4 24
$15.2M
$33.5M
Q3 24
$9.9M
$8.0M
Q2 24
$33.5M
$9.9M
Q1 24
$45.0M
$6.4M
Free Cash Flow
IRWD
IRWD
PSTL
PSTL
Q4 25
$74.6M
$37.6M
Q3 25
$47.6M
$8.8M
Q2 25
$-15.1M
$9.1M
Q1 25
$19.9M
$10.2M
Q4 24
$30.7M
Q3 24
$9.9M
$7.4M
Q2 24
$33.4M
$8.9M
Q1 24
$44.9M
$5.8M
FCF Margin
IRWD
IRWD
PSTL
PSTL
Q4 25
156.3%
144.5%
Q3 25
39.0%
36.1%
Q2 25
-17.7%
38.8%
Q1 25
48.4%
45.9%
Q4 24
143.8%
Q3 24
10.8%
37.6%
Q2 24
35.4%
49.4%
Q1 24
60.0%
33.6%
Capex Intensity
IRWD
IRWD
PSTL
PSTL
Q4 25
0.0%
26.7%
Q3 25
0.0%
8.9%
Q2 25
0.0%
10.1%
Q1 25
0.1%
3.0%
Q4 24
0.0%
13.0%
Q3 24
0.0%
3.2%
Q2 24
0.1%
5.4%
Q1 24
0.1%
3.5%
Cash Conversion
IRWD
IRWD
PSTL
PSTL
Q4 25
9.59×
Q3 25
1.19×
2.87×
Q2 25
-0.64×
3.16×
Q1 25
5.20×
Q4 24
6.74×
7.44×
Q3 24
2.71×
7.48×
Q2 24
12.10×
Q1 24
31.07×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons